Company story

We Made Inositol the Language of Health and Care.

Rooted in Italian science, dedicated to improving lives and health across the world.

2001
Expanded
Origins and Mission

Lo.Li. Pharma was founded with the mission of advancing women’s health in Rome -Italy, through the research, development, and distribution of innovative products designed to support women at every stage of life. Guided by scientific rigor and a deep understanding of female physiology, the company has become a trusted partner for healthcare professionals and patients alike, offering effective, evidence-based solutions that promote wellbeing, balance, and quality of life.

Our founder, renowned gynecologist Professor Vittorio Unfer, MD, and the world’s leading authority on inositols, continues to guide our scientific mission.

His co-founding of the prestigious Experts Group on Inositol in Basic and Clinical Research (EGOI)reflects our unwavering commitment to advancing the science of women's health.

With over 200 scientific publications to his name, Professor Unfer has helped shape a new understanding of conditions like PCOS, insulin resistance, and gestational diabetes.

His research has transformed clinical practice and improved the quality of life for countless women around the world — turning molecular insight into measurable, personal change.

Collaboration is key to our success. Working hand-in-hand with universities, hospitals, and clinical research centers — both in Italy and across the globe — our skilled team of Ph.D. scientists leads a wide range of research initiatives that push the boundaries of what’s possible in healthcare.

Our work is regularly presented at major national and international medical congresses, including the European Society of Human Reproduction and Embryology (ESHRE), the International Society of Gynecological Endocrinology (ISGE), and many others — a testament to our scientific presence and recognition on a truly global scale.

In the world of food supplements and medical devices, claims of scientific backing are common. However, many competitive products lack the necessary clinical evidence, leading to uncertainties about their safety and effectiveness. This can be a concern for healthcare professionals and consumers alike.

At Lo.Li. Pharma International, we set a higher standard. Almost all our products are supported by clinical trials, which have been published in a variety of peer-reviewed medical journals and featured at international scientific conferences. This strong foundation of clinical evidence fosters trust and acceptance among physicians and consumers.

Our expertise shines in introducing first-of-their-kind products to new markets. Behind every successful launch is our skilled Research and Development team. They work closely with researchers and clinicians to support the development of scientific content — ensuring each product is framed within the latest clinical evidence and research trends.

This plan ensures continuous sharing of scientific updates in the field, reinforcing our commitment to innovation and knowledge dissemination.

2009
Expanded
First Steps Abroad

Lo.Li. Pharma began its international expansion by establishing strategic collaborations with partners in South Africa, Bulgaria, and several other countries, marking the first step toward bringing its innovative approach to women’s healthcare to a global scale.

2012
Expanded
Birth of Lo.Li. Pharma International

The growing number of international partnerships led to the establishment of Lo.Li. Pharma International, a company specifically dedicated to developing and expanding Lo.Li. Pharma’s presence in global markets.

2023
Expanded
Establishing a Presence in the United States

To reinforce its foothold in the United States, Lo.Li. Pharma founded Lo.Li. Pharma USA, with the goal of expanding market presence and exploring new strategic business opportunities.

2025
Introduced
A Global Reach

Lo.Li. Pharma’s products are now distributed in more than 70 countries across the globe, confirming the brand’s international reach and reputation.

New Logo. Same essence.

New Logo.
Same essence.